combination glp-1 and sglt2 Updated evidence on cardiovascular renal effects of receptor agonists and therapy with inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology SGLT2 Inhibitors and GLP-1 Receptor

Additionally, as previously mentioned, a recent study has described that MetS -taking the harmonised definition criteria for diagnosisis a better predictor for CVD than the sum of each of its separate components or the Framingham Score

Potential side effects include: Water retention (especially early in the protocol) Mild joint discomfort or stiffness Temporary fatigue or lethargy Flushing or warmth at the injection site Headaches (typically mild and transient) Most side effects are dose-dependent and resolve with dosage adjustment

The research on GLP-1s impact on addictive behaviors creates new treatment possibilities for patients facing substance use challenges alongside weight concerns

In many cases, they normalize as dosing stabilizes, side effects improve, nutrition normalizes and the body adjusts. However, if changes are persistent or distressing, they deserve to be taken seriously and managed, he added

Ventola CL

72 StanleyTLFeldpauschMNOhJBranchKLLeeHTorrianiMet al